NOCQuarterly earnings21 Apr 2026
Northrop Grumman

Q1 2026: Aeronautics growth and B-21 capacity funding strengthened long-term demand, but a Space charge, higher capex and withdrawal of the 2028 FCF target drove a sharp selloff.

ResultIn line / mixedGuidanceMaintainedEnvironmentmixed
Investment snapshot

What happened and why it mattered

Print

In line / mixed

Aeronautics revenue rose 17%, while Space Systems recorded a $71M charge. B-21 capacity was planned to rise 25%, supported by $4.5B of government funding and $2.5B of company investment. Management withdrew its prior roughly $4B 2028 free-cash-flow target.

[AS-055]
Guidance

Maintained

2026 sales, operating income and FCF were held, but capex rose $200M to about $1.85B and the 2028 FCF target was removed.

[AS-055]
Implied growth

No clear inflection

Near-term operating guidance stayed intact, while a larger investment cycle delayed the medium-term cash inflection.

[AS-055]
Stock reaction

-7.0%

The 7% decline reflected reduced confidence in the timing and visibility of free cash flow rather than weak demand.

[MKT-001]
Results versus expectations

The print and the three most important read-throughs

Aeronautics revenue rose 17%, while Space Systems recorded a $71M charge. B-21 capacity was planned to rise 25%, supported by $4.5B of government funding and $2.5B of company investment. Management withdrew its prior roughly $4B 2028 free-cash-flow target.

  1. 1

    Aeronautics revenue rose 17%, while Space Systems recorded a $71M charge.

  2. 2

    B-21 capacity was planned to rise 25%, supported by $4.5B of government funding and $2.5B of company investment.

  3. 3

    Management withdrew its prior roughly $4B 2028 free-cash-flow target.

[AS-055]
Guidance bridge

Latest outlook and KPI implications

GuidanceMaintained

2026 sales, operating income and FCF were held, but capex rose $200M to about $1.85B and the 2028 FCF target was removed.

MetricPriorLatestConsensusDeltaStatusReason / implication
2026 sales$43.5–44.0B$43.5–44.0BNot consistently availableNo changeReiteratedBacklogProduction growth intact
2026 segment operating incomeExisting rangeReiteratedNot consistently availableNo changeReiteratedProgram mixCharges absorbed within plan
2026 free cash flow$3.1–3.5B$3.1–3.5BNot consistently availableNo changeReiteratedCash timingStill achievable but capex-heavy
2026 capexApproximately $1.65BApproximately $1.85BNot consistently available+$200MRaisedB-21 capacityReduces near-term FCF
2028 free cash flowApproximately $4B targetTarget withdrawnNot applicableRemovedWithdrawnInvestment scope and timingMedium-term visibility reduced
Management signal — paraphrased

The environment supported sales and backlog but raised capex and reduced visibility on out-year free cash flow. The affected KPIs were Aeronautics growth, Defense Systems growth, capex and FCF.

Implied cadence

Near-term operating guidance stayed intact, while a larger investment cycle delayed the medium-term cash inflection.

[AS-055]
Stock reaction

Why the shares moved

The 7% decline reflected reduced confidence in the timing and visibility of free cash flow rather than weak demand.

  • 2028 FCF target withdrawn
  • Capex raised
  • B-21 capacity opportunity
Did the reaction persist?

The roughly 7% first-day decline persisted.

[MKT-001]
Adjusted-close reaction
WindowStockvs benchmarkvs peers
1D-7.0%-6.3%-5.2%
2D-10.3%-10.7%-6.3%
5D-12.4%-13.3%-3.6%
Independently calculated adjusted-close returns
Market environment delta

What management said about the operating backdrop

Environmentmixed

Defense demand firmed, but the B-21 opportunity crystallized into a company-funded capacity obligation that pushed cash returns outward.

Demand
  • B-21 production cadence (Aeronautics)Improved / firmed

    Q1'26: agreement finalized to lift annual rate 25%, backed by customer reconciliation funds plus ~$2.5bn company-funded investment, primarily new facilities.

    OutlookModest 2026 revenue step-up; larger ramp and step-change in sales "a couple of years later" once infrastructure is in place.KPI implicationCapex (~$1.85bn), Aeronautics sales, out-year FCFDISCLOSED FACT · High confidence · [228]
  • Sentinel (Defense Systems)Improved / accelerated

    Q1'26: agreement to accelerate toward Milestone B later in 2026, first flight 2027, IOC early 2030s; prototype launch silo tube broke ground.

    OutlookDouble-digit growth in 2026; profitability unchanged with no charge; acceleration from Nunn-McCurdy timeline.KPI implicationDefense Systems sales, backlogDISCLOSED FACT · High confidence · [229] [230]
  • International demand & geographyStrengthened

    Q1'26: heightened Middle East urgency for IBCS, G/ATOR and Counter-UAS; robust European demand to buy US products.

    OutlookInternational outpaces domestic but on a longer cycle; conversions "largely seen beyond this year."KPI implicationMulti-segment sales, book-to-billMANAGEMENT INTERPRETATION · High confidence · [233] [234]
Supply
  • Solid rocket motor / munitions capacity (supply constraint)Constraint easing

    Q1'26: tactical SRM capacity doubled since 2021, further 50% expansion (effectively tripling) at ABL West Virginia by early 2027; second-source qualification on PAC-3.

    OutlookWeapons (~10% of sales) to grow well above company average; framework agreements at peers positive for NOC's SRM supply role.KPI implicationDefense Systems sales, marginsMANAGEMENT INTERPRETATION · High confidence · [231] [232]
  • Supply chain / raw materials & laborNO MATERIAL CHANGE

    Q1'26: helping suppliers resource their own scaling; training workforce for F-35 radar ramp and F/A-XX readiness.

    OutlookDetailed operations planning with supply chain investing in tandem; binding constraints being actively managed.KPI implicationProgram execution, marginsMANAGEMENT INTERPRETATION · Medium confidence · [243] [244]
Competition
  • F/A-XX competition (Aeronautics)Catalyst approaching

    Q1'26: NOC and suppliers "prepared to bring the workforce and infrastructure needed to execute"; Navy affirmed August award timing.

    OutlookAward decision expected August; a win valued at ~$5.3bn NPV or ~$37/share, not in numbers.KPI implicationAeronautics sales, capexBROKER/PEER EVIDENCE · Medium confidence · [237] [238]
  • Contracting model / pricing & cost pass-throughStructurally shifted

    Q1'26: shift toward OTAs and nontraditional mechanisms; incentives on contracts to drive early delivery, balancing affordability.

    Outlook"Pay to play" requires higher company-funded investment with deferred returns; near-term FCF estimates must fall.KPI implicationFCF, capex, out-year targetsBROKER/PEER EVIDENCE · High confidence · [241] [242]
[AS-ME-055]
Evidence and confidence

Source map

Consensus snapshots are reconstructed from contemporaneous broker notes; the flattened AlphaSense export does not preserve stable document URLs.

Restricted synthesisAS-ME-055

AlphaSense market-environment synthesis

Open source ↗